Background
==========

Oxidative stress-induced neuronal damage has been implicated in many neurodegenerative disorders including Parkinson\'s disease (PD), Alzheimer\'s diseases, ALS, Huntington\'s diseases and stroke \[[@B1]-[@B7]\]. Neuronal cells maintain an oxidant/antioxidant homeostatic balance, and any breach in redox homeostasis causes excessive ROS production, resulting in oxidative damage \[[@B8]-[@B10]\]. Oxidative stress triggers apoptosis through activation of many signaling molecules including kinases and proteases \[[@B11]-[@B15]\], and the roles of these signaling molecules in dopaminergic cell death are being actively investigated. Recently, we demonstrated that the proteolytic activation of PKCδ, a novel PKC family member, mediates apoptosis in cell culture and animal models of PD \[[@B15]-[@B19]\].

PKCδ can be activated by membrane translocation, phosphorylation, or proteolytic cleavage by caspase-3, leading to persistently active catalytic fragments. We previously showed that various oxidative stressors like H~2~O~2~, MPP^+^and 6-OHDA induce PKCδ cleavage to increase the kinase activity and apoptosis in dopaminergic cells \[[@B20],[@B15],[@B21],[@B16]\]. The time course studies revealed that the pro-apoptotic proteolytic activation of PKCδ occurs well before apoptotic cell death, and that cells resist early oxidative damage, suggesting that some key intrinsic compensatory responses protect neurons from the initial oxidative insult. Therefore, we speculated that the persistently active catalytic fragment of PKCδ might have other functions during the early stages of oxidative stress, and so we further explored downstream signaling mechanisms.

Protein kinase D1 (PKD1) is a calcium/calmodulin-dependent member of the CAMK kinase family and can be activated by dual phosphorylation of seine residues (Ser 744/748) in the catalytic domain by different PKCs, depending upon the cellular type and stimuli \[[@B22]-[@B24]\]. PKD1 is activated in response to multiple stimuli including growth factors, phorbol esters, G-protein coupled receptors, genotoxic stress and oxidative stress \[[@B25]-[@B28]\]. In non-neuronal cells, PKD1 activation has been shown to play a role in diverse cellular functions including proliferation, cytoskeletal reorganization, golgi function and immune response \[[@B27],[@B29]-[@B32]\]. PKD1 has been shown to regulate various cell signaling molecules and pathways including ERK1/2, JNK pathways \[[@B33]-[@B35]\], effector enzymes like MnSOD that scavenge ROS \[[@B31],[@B36]\], transcriptional regulators including NF-κB and MEF2 \[[@B37],[@B38]\], stress responsive chaperones like HSP27 \[[@B39]\], and some members of the HDAC family \[[@B26],[@B31],[@B40]\]. Recently, PKD1 was recognized as an important mitochondrial ROS sensor that translocates to the nucleus to switch on cell survival mechanisms \[[@B36]\]. Also, PKD1 activation loop phosphorylation has been shown as an early marker of sympathetic neuronal DNA damage \[[@B41]\]. In neuronal models, PKD1 regulates trafficking of dendritic membrane proteins to maintain neuronal polarity and synaptic plasticity \[[@B42]\].

While many biological functions of PKD1 are beginning to emerge, the role of PKD1 in the brain, specifically in the nigral dopaminergic system, remains unknown. The relationship between PKD1 signaling and neurodegeneration has not yet been examined in a single study. Herein, we demonstrate that PKD1 closely interacts with PKCδ and serves as a key compensatory protective mechanism in dopaminergic neuronal cells during the early stages of oxidative insult.

Results
=======

Role of PKCδ cleavage in the early stages of H~2~O~2~-induced oxidative stress in dopaminergic neuronal cells
-------------------------------------------------------------------------------------------------------------

H~2~O~2~is a common oxidative insult used to probe various cellular signaling pathways in different cell types including neuronal cells \[[@B15],[@B43],[@B44]\]. We have already demonstrated that H~2~O~2~causes dose- and time-dependent cytotoxicity, DNA fragmentation and cell death in the dopaminergic neuronal N27 cell model \[[@B15]\]. In order to determine the interrelationship between PKCδ proteolytic cleavage and oxidative stress-induced cell death, we examined the time course of PKCδ proteolytic activation and cell death. As shown in Figure [1A](#F1){ref-type="fig"}, generation of ROS occurs as early as 1 h after H~2~O~2~treatment. Cytotoxicity begins between 90 and 120 min (Figure [1B](#F1){ref-type="fig"}). PKCδ proteolytic cleavage and the kinase activity increases during the early stage of H~2~O~2~exposure at 60 min (Figure [1C, D](#F1){ref-type="fig"}). Comparison of PKCδ proteolytic activation and cytotoxicity at 60 min revealed that PKCδ proteolytic activation occurs during the early stages of oxidative stress preceding cell death (Figure [1E](#F1){ref-type="fig"}). There was no cell death during this intermediate period between ROS generation and PKCδ proteolytic activation. PKCδ knockdown by RNAi almost completely blocked the cell death induced by H~2~O~2~at 120 min of treatment, demonstrating the pro-apoptotic function performed by PKCδ in N27 cells (Figure [1F](#F1){ref-type="fig"}). Importantly, a significant lag period between induction of cell death and PKCδ proteolytic activation was observed. This interesting observation prompted a search for cell signaling mechanisms associated with a compensatory protective response involving PKCδ proteolytic activation during early stages of oxidative stress.

![**Relationship between PKCδ proteolytic activation and cell death during initial stages of H~2~O~2~-induced oxidative stress in N27 dopaminergic neuronal cell model**. N27 dopaminergic cells were treated with H~2~O~2~(100 μM) for 0-180 min and assayed for ROS generation using DCFDA dye (A) and for cytotoxicity using Sytox green dye (B). Non-linear regression graph from two or more independent experiments (n = 6-8). PKCδ cleavage was monitored by Western blot in a time dependent manner for 0 - 90 min in N27 dopaminergic cells treated with H~2~O~2~(100 μM) (C). N27 dopaminergic cells were treated with H~2~O~2~(100 μM) for 0, 30 or 60 minutes and PKCδ kinase activity was measured using \[^32^P\] kinase assay; the bands were quantified for the graph (D). Data quantified from B and C were used to generate a bar graph and were compared with cytotoxicity and PKCδ cleavage following H~2~O~2~exposure for 60 min. \*\*, p \< 0.01 as indicated by two-way ANOVA analysis using Bonferroni post test (E). N27 cells were transfected with 1 μM PKCδ siRNA and non-specific siRNA for 24 h and treated with 100 μM H~2~O~2~and monitored for cytotoxicity using Sytox green dye, which showed significant protection from oxidative stress. \*\*\*, p \< 0.001 denotes significant difference between non-specific siRNA- H~2~O~2~and PKCδ siRNA H~2~O~2~-treated groups from two or more independent experiments (n = 6-8). Statistics were performed by one-way ANOVA analysis using Bonferroni post test (F).](1750-1326-6-43-1){#F1}

Oxidative stress induces phosphorylation and activation of PKD1 in a time-dependent manner
------------------------------------------------------------------------------------------

We hypothesized that the proteolytically cleaved PKCδ might activate other downstream cell survival signaling molecules to counteract the early stage of oxidative insult. To test this hypothesis, we first used a bioinformatic approach to search for a key pro-survival molecule that interacts with PKCδ. Scansite Motif Scanner software \[[@B45]\] predicted that out of all the PKCs, only PKCδ can phosphorylate the protein kinase D1 (PKD1) activation loop ser residue at high stringency search (additional file [1](#S1){ref-type="supplementary-material"}). Further literature review indicated that PKD1 is an oxidative stress-responsive kinase that can be activated by phosphorylation at the activation loop (S744/S748) in non-neuronal models \[[@B22]-[@B25],[@B46]\]. This encouraged us to look further for the expression and activation of PKD1 in dopaminergic neuronal cells. Immunocytochemical staining showed abundant expression of PKD1 in N27 dopaminergic cells, as visualized by confocal and fluorescence microscopy (Figure [2A](#F2){ref-type="fig"}), which is similar to the expression pattern of PKCδ in this cell type. Importantly, PKD1 is also highly expressed in primary tyrosine hydroxylase (TH) positive dopaminergic neurons obtained from mouse substantia nigra in the cytosolic region (Figure [2B](#F2){ref-type="fig"}).

![**PKD1 is highly expressed in dopaminergic neurons and activated during initial stages of H~2~O~2~-induced oxidative stress**. Immunofluorescence analysis of N27 dopaminergic cells stained for native PKD1 using fluorescence and confocal microscopy. Nuclei were stained with Hoechst dye (A). Primary dopaminergic neurons staining for tyrosine hydroxylase (TH) obtained from the mouse substantia nigral region show co-localization of native PKD1 with TH. TH - Green, PKD1 native - Red, Nucleus - Blue, Yellow -Merge. Nuclei were stained with Hoechst dye (B). N27 dopaminergic neuronal cells were treated with or without H~2~O~2~(100 μM) for 30, 60 or 90 min and probed for PKD1 activation loop phosphorylation pS744/pS748 and native PKD1 expression (C). N27 cells were treated with or without H~2~O~2~(100 μM) and PKD1 kinase activity was measured by \[^32^P\] kinase assay using syntide 2 substrate at 60 min (D). \*, p \< 0.05 denotes significant difference between untreated and H~2~O~2~-treated groups.](1750-1326-6-43-2){#F2}

To determine if oxidative stress can induce PKD1 Ser 744/Ser 748 phosphorylation in the activation loop, we examined the ability of H~2~O~2~to induce time-dependent PKD1 activation loop phosphorylation in N27 dopaminergic cells. As shown in Figure [2C](#F2){ref-type="fig"}, 100 μM H~2~O~2~induced transient PKD1 activation loop phosphorylation corresponding to the 120 kDa band starting at around 30 min, peaking at 60 min and returning to control levels after 90 min, with native protein levels remaining the same. We also observed a second band around 100 kDa, which might correspond to the other isoform, PKD2. According to the manufacturers (Cell Signaling Technology), the phospho-specific antibody can also detect PKD2 Ser 706/Ser 710 phosphorylation because of the conserved activation loop residues between PKD isoforms. However, the PKD2 activation loop phosphorylation does not follow the transient pattern of activation observed with PKD1 (Figure [2C](#F2){ref-type="fig"}). Furthermore, the activation loop phosphorylation of PKD1 increased the PKD1 kinase activity, as measured by a \[^32^P\] kinase assay using Syntide 2 substrate (Figure [2D](#F2){ref-type="fig"}). Collectively, these results demonstrate that oxidative stress activates PKD1 at early stages through phosphorylation of the dual phospho sites pS744/pS748.

Oxidative stress-induced PKD1 activation depends on PKCδ
--------------------------------------------------------

To further determine whether PKCδ regulates PKD1, we used both pharmacological and genetic approaches to suppress the PKCδ and then measured the level of PKD1 activation. Treatment of N27 cells with the PKCδ inhibitor rottlerin (1 μM) completely suppressed H~2~O~2~-induced PKD1 activation (Figure [3A](#F3){ref-type="fig"}), suggesting a potential role of PKCδ in PKD1 activation. Next, we used the PKCδ-specific siRNA to knockdown PKCδ and then probed for PKCδ expression and PKD1 phosphorylation. PKCδ knockdown completely attenuated PKD1 activation loop phosphorylation except for the bottom band, corresponding to 100 kDa PKD2 (Figure [3B](#F3){ref-type="fig"}). Furthermore, PKD1 activity was measured by \[^32^P\] kinase assay in PKCδ knockdown samples. The suppression in PKCδ expression completely attenuated PKD1 activation during H~2~O~2~-mediated oxidative stress, confirming that PKCδ is indeed involved in PKD1 activation (Figure [3C](#F3){ref-type="fig"}). To show the specificity of PKCδ in PKD1 activation in neuronal models, we used PKCα siRNA and then measured PKD1 activation loop phosphorylation (additional file [2](#S2){ref-type="supplementary-material"}). Knockdown of PKCα did not attenuate PKD1 activation loop phosphorylation, further demonstrating the specificity of PKCδ-mediated PKD1 phosphorylation in dopaminergic neuronal models.

![**PKCδ dependent phosphorylation of PKD1 activation loop**. N27 dopaminergic cells were treated with H~2~O~2~(100 μM) with or without 1 μM rottlerin, and the lysates were probed for PKD1 activation phosphorylation (A). N27 dopaminergic cells were transfected with 1 μM PKCδ siRNA and non-specific siRNA and monitored for PKCδ protein expression and PKD1 activation loop phosphorylation after H~2~O~2~treatment (B) and PKD1 kinase activity assay was performed. \*\*, p \< 0.01 denotes significant difference between NS-siRNA-H~2~O~2~and PKCδ-siRNA-H~2~O~2~groups (C).](1750-1326-6-43-3){#F3}

The constitutively active catalytic fragment of PKCδ mediates PKD1 activation
-----------------------------------------------------------------------------

Time course analysis of PKCδ proteolytic cleavage and PKD1 activation revealed that the onset of proteolytic activation of PKCδ coincides with the maximal activation of PKD1 at 60 min following H~2~O~2~-induced oxidative stress (Figure [4A](#F4){ref-type="fig"}). Previously, we had shown that caspase-3 inhibitor z-DEVD-fmk and pan caspase inhibitor ZVAD-fmk attenuate H~2~O~2~-induced proteolytic activation of PKCδ. Therefore, we examined whether the proteolytically activated PKCδ contributes to PKD1 activation. As shown in Figure [4B](#F4){ref-type="fig"}, co-treatment with z-DEVD-fmk and ZVAD-fmk for 1 h significantly blocked H~2~O~2~-induced activation loop phosphorylation of PKD1 as well as proteolytic cleavage of PKCδ. Coincidentally, H~2~O~2~-induced activation loop phosphorylation of PKD2 was not affected in the presence of these caspase inhibitors. To further confirm the role of proteolytically activated PKCδ in PKD1 activation, we used N27 cells stably expressing the PKCδ cleavage-resistant mutant PKCδ^D327A^(PKCδ-CRM). H~2~O~2~treatment in PKCδ-CRM cells significantly attenuated PKD1 phosphorylation, confirming that the proteolytically cleaved PKCδ contributes to PKD1 phosphorylation during early stages of oxidative stress (Figure [4C](#F4){ref-type="fig"}). To further support this observation, we separately over-expressed the PKCδ catalytic fragment (V5-PKCδ-CF) and PKCδ regulatory fragment (V5-PKCδ-RF) using a lentiviral vector (plenti6/V5-D-TOPO) in N27 cells and then evaluated for activation of PKD1. Interestingly, V5-PKCδ-CF over-expressing cells had increased PKD1 phosphorylation, while V5-PKCδ-RF over-expressing cells did not increase phospho-PKD1 levels (Figure [4D](#F4){ref-type="fig"}). Collectively, these results demonstrate that the constitutively active catalytic fragment of PKCδ mediates PKD1 activation loop phosphorylation.

![**Proteolytically activated PKCδ-CF contributes to PKD1 phosphorylation**. N27 dopaminergic cells treated with H~2~O~2~(100 μM) for 30, 60 or 90 minutes were monitored for PKCδ-CF (A). N27 dopaminergic cells were treated with H~2~O~2~± DEVD-fmk (50 μM) and ± ZVAD-fmk (50 μM and 100 μM) for 60 min and monitored for PKD1 activation and PKCδ cleavage (B). N27 dopaminergic cells stably expressing the cleavage-resistant mutant of PKCδ (PKCδ^D327A^) were treated with H~2~O~2~and monitored for PKD1 activation (C). PKD1 activation was monitored in N27 dopaminergic cells transfected with the catalytic fragment of PKCδ (PKCδ-CF) and the regulatory fragment of PKCδ (PKCδ-RF). Additionally, the mock transfection group treated with or without H~2~O~2~was also monitored for PKD1 activation (D).](1750-1326-6-43-4){#F4}

PKD1 activation functions as an anti-apoptotic protective mechanism against oxidative stress
--------------------------------------------------------------------------------------------

We previously reported that proteolytically activated PKCδ (PKCδ-CF) mediates apoptosis in neurotoxicity models \[[@B15],[@B19],[@B47]\] and therefore, we initially hypothesized that PKCδ proteolytic cleavage-dependent activation of PKD1 may have a proapoptotic function. Surprisingly, PKD1 knockdown siRNA significantly augmented H~2~O~2~-induced cell death at 2 h, as measured by Sytox cell death assay (Figure [5A](#F5){ref-type="fig"}). PKD1 knockdown increased cell death by nearly twofold compared to control groups during H~2~O~2~treatment, indicating a pro-survival role for PKD1 against oxidative stress (Figure [5B](#F5){ref-type="fig"}). Visualization of PKD1 knockdown cells by phase contrast and fluorescence microscopy further confirmed that PKD1 knockdown cells are more sensitive than non-specific control cells to H~2~O~2~-induced cytotoxicity (Figure [5C](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}). We further measured the H~2~O~2~-induced apoptosis in PKD1 knockdown cells by DNA fragmentation ELISA assay at 3 h. The results showed an increase in DNA fragmentation in the PKD1 knockdown group, as compared to the non-specific siRNA control group, further confirming the anti-apoptotic role of PKD1 in dopaminergic cells (Figure [5E](#F5){ref-type="fig"}).

![**PKD1 has a cell survival function during oxidative stress in dopaminergic neuronal cells**. N27 dopaminergic cells were transfected with 1 μM PKD1 siRNA and non-specific siRNA (A) and treated with 100 μM H~2~O~2~for 120 minutes and monitored for cytotoxicity using Sytox green dye. Fluorescence measurements for the incorporation of Sytox green read using a flourescence plate reader (B) and visualised by phase contrast and fluorescence microscopy (C&D). DNA fragmentation assay (E) showed increased cytotoxicity and apoptosis in PKD1 knocked down samples exposed to H~2~O~2~. \*, p \< 0.05 and \*\*\*, p \< 0.001 denote significant difference between Non-Specific siRNA- H~2~O~2~and PKD1 siRNA-H~2~O~2~treated groups.](1750-1326-6-43-5){#F5}

PKD1 C-terminal Ser 916 phosphorylation precedes PKD1 Ser 744/Ser 748 activation loop phosphorylation during oxidative stress
-----------------------------------------------------------------------------------------------------------------------------

We also characterized the sequential mechanisms of PKD1 activation in dopaminergic neuronal cells. We investigated the other two key phosphorylation sites of PKD1, Tyr 469 and Ser 916. As shown in Figure [6A](#F6){ref-type="fig"} H~2~O~2~-induces transient phosphorylation of PKD1 Ser 916 in a time-dependent manner. The data suggests that PKD1 C-terminal Ser 916 was rapidly phosphorylated as early as 10 min after H~2~O~2~treatment continues to increase up to 90 min and decreases at 150 min (Figure [6A](#F6){ref-type="fig"}). The phospho PKD1-pS916 antibody detects a doublet PKD1 band. On the other hand, H2O2 failed to induce PKD1-tyr 469 phosphorylation in N27 dopaminergic cells (Figure [6A](#F6){ref-type="fig"}). Our results are consistent with a previous study suggesting that PKD1 tyr 469 phosphorylation does not occur in H~2~O~2~-treated Swiss 3T3 cells \[[@B48]\]. Similarly, it was shown that Vasopressin a GPCR agonist can activates PKD1 in Swiss 3T3 cells \[[@B30]\]. Since H~2~O~2~did not phosphorylate tyr 469, we used desmopressin, a synthetic analogue of vasopressin to induce tyr 469 phosphorylation. Exposure of N27 dopaminergic cells to the positive control desmopressin induced tyr 469 phosphorylation (Figure [6B](#F6){ref-type="fig"}). To further evaluate the involvement of PKD1 Ser 916 phosphorylation in PKD1 activation, we overexpressed the PKD1^S916A^mutant and PKD1^WT^plasmids in dopaminergic cells and then stimulated the cells with H~2~O~2~. Overexpression of PKD1^S916A^mutant blocked PKD1 activation loop phosphorylation (Figure [6C](#F6){ref-type="fig"}), suggesting that Ser 916 phosphorylation is an early event that has to occur prior to PKD1 activation loop phosphorylation. Furthermore, knockdown of PKCδ attenuated PKD1^S916^phosphorylation, demonstrating that this is PKCδ dependent (Figure [6D](#F6){ref-type="fig"}). Together, these results suggest that PKD1 Ser 744/Ser 748 activation loop phosphorylation is intrinsically regulated by PKCδ via C-terminal phosphorylation of PKD1 Ser916.

![**PKCδ-dependent phosphorylation of PKD1 at S916 site precedes PKD1 S744/S748 active loop phosphorylation**. N27 dopaminergic cells were treated with 100 μM H~2~O~2~for 10-90 min and monitored for PKD1Y469, PKD1 S916 and PKD1 S744/S748 phosphorylation (A). N27 dopaminergic cells were treated with or without 50 nM desmopressin for 1 h and monitored for PKD1 Y469 phosphorylation. The cells show PKD1 Y469 phosphorylation when exposed to desmopressin, while carbachol does not cause PKD1 Y469 phosphorylation (B). N27 cells expressing PKD1^S916A^mutant blocked PKD1 activation during oxidative stress, as seen by Western blotting for PKD1 S744/S748 phosphorylation and HA expression (C). N27 dopaminergic cells were transfected with 1 μM PKCδ siRNA and non-specific siRNA and monitored for PKCδ protein expression and PKD1 S916 phosphorylation after treatment with or without H~2~O~2~(D).](1750-1326-6-43-6){#F6}

PKD1 activation acts as a protective compensatory mechanism during early stages of oxidative stress
---------------------------------------------------------------------------------------------------

To understand the relationship between PKCδ/PKD1 activation and neuronal cell death during oxidative stress, we quantified the PKCδ/PKD1 activation profile from the Western blots and then compared them with the profile of neuronal cell death during H~2~O~2~-induced oxidative stress. As shown in Figure [7A](#F7){ref-type="fig"}, PKD1 was activated at the early stages of oxidative insult and no measurable cell death was observed until PKD1 activation started declining to basal levels. Alternatively, PKCδ activation was concomitantly increased along with H~2~O~2~-induced cytotoxic cell death at the later stage of oxidative stress. Thus, the inverse correlation of PKD1 activation with cytotoxicity suggests that PKD1 activation may act as a compensatory protective response during early stages of oxidative insult. To test this hypothesis, we first overexpressed the full-length human PKD1 (PKD1^WT^) in N27 cells and then examined the H~2~O~2~-induced cytotoxicity. As anticipated, PKD1^WT^overexpression protected the dopaminergic cells against oxidative stress-induced cytotoxicity at 2 h (Figure [7B](#F7){ref-type="fig"}). In order to establish the pro-survival function of PKD1 activation, we examined whether overexpression of the PKD1^S916A^phosphorylation defective mutant exacerbated H~2~O~2~-induced neuronal cell death. As shown in Figure [7C](#F7){ref-type="fig"}, overexpression of the PKD1^S916A^phosphorylation defective mutant exacerbated H~2~O~2~-induced cytotoxic cell death as early as 90 minutes, compared to vector overexpressing cells. To further confirm our hypothesis that PKD1 activation loop phosphorylation acts as an early protective compensatory response, we overexpressed the activation loop active plasmid (PKD1^S744E^/^S748E^), where the replacement of serine with glutamate makes the kinase constitutively active \[[@B49]\], and cytotoxicity was monitored for up to 3h following H~2~O~2~treatment (Figure [7D](#F7){ref-type="fig"}). The constitutively active PKD1 mutants tremendously suppressed the cytotoxicity, even during late stages of oxidative insult, indicating that PKD1 activation is a very significant early protective compensatory mechanism in dopaminergic cells. Collectively, these results demonstrate that PKD1 is a cell survival kinase that is activated during the early stages of oxidative stress to protect against cytotoxicity in dopaminergic cell models.

![**PKD1 activation acts as an early protective compensatory mechanism**. A comparative time course graph based on quantifying PKD1 activation profile, PKCδ cleavage profile and cytotoxicity during H~2~O~2~exposure (A). N27 dopaminergic cells transiently transfected with 5 μM full length PKD1 plasmid (PKD1^WT^) and 5 μM vector plasmid were treated with or without 100 μM H~2~O~2~for 150 minutes and monitored for cytotoxicity using sytox green; PKD1 protected against cytotoxicity (B). N27 dopaminergic cells transiently transfected with 5 μM PKD1^S916A^plasmid and 5 μM vector plasmid were treated with or without 100 μM H~2~O~2~for 150 minutes and monitored for cytotoxicity using sytox green; increased cytotoxicity was observed in the cells (C). N27 dopaminergic cells transiently transfected with 5 μM PKD1^S744E/S748E^and 5 μM vector plasmid (D) were treated with or without 100 μM H~2~O~2~and monitored for cytotoxicity at various time points using sytox green. \*\*\*, p \< 0.001 denotes significant difference between treatment groups from n≥6.](1750-1326-6-43-7){#F7}

Activated PKD1 translocates to nucleus during oxidative stress in cell culture models of neurodegeneration
----------------------------------------------------------------------------------------------------------

We also performed immunocytochemical staining to examine the subcellular localization of activated PKD1 during oxidative stress. Activated PKD1 (PKD1pS744/pS748) (green) co-localized with the nuclear Hoechst stain (blue) at 1 h during H~2~O~2~-induced oxidative stress in N27 cells, as visualized by fluorescence microscopy (Figure [8A](#F8){ref-type="fig"}). These results indicate that activated PKD1 translocates to the nucleus of dopaminergic neuronal cells to carry out cell repair and survival functions.

![**Activated PKD1 translocates to nucleus during H~2~O~2~-induced oxidative stress**. Immunofluorescence analysis of N27 dopaminergic cells stained for activated PKD1 using fluorescence microscopy during H~2~O~2~exposure show translocation to nucleus. PKD1pS744/S748 - Green, Nucleus - Blue. Nuclei were stained with Hoechst dye (A). Immunofluorescence analysis of primary dopaminergic neurons staining for TH obtained from the mouse substantia nigral region shows translocation of activated PKD1 to the nucleus during H~2~O~2~exposure.TH-Green, PKD1pS744/S748 - Red, Nucleus - Blue, Merge - Pink. Nuclei were stained with Hoechst dye (B). Primary dopaminergic neurons staining for TH show presence of PKD1pS916 in both cytosol and nucleus during H~2~O~2~exposure. TH - Green, PKD1pS916- Red, Nucleus - Blue, Pink - Merge in nucleus, yellow -Merge in cytosol. Nuclei were stained with Hoechst dye (C).](1750-1326-6-43-8){#F8}

Furthermore, we examined oxidative stress-induced PKD1 activation in primary mesencephalic dopaminergic neurons. Mouse primary mesencephalic neuronal cultures were treated with a low dose of 10 μM H~2~O~2~to induce oxidative stress and then subcellular localization of PKD1 activation was monitored by TH/PKD1 double immunolabeling. Activated PKD1 (red) (PKD1 pS744/pS748) co-localized (pink) with the nuclear Hoechst stain (blue) following H~2~O~2~treatment in primary mesencephalic neurons staining for TH (green), as visualized by fluorescence microscopy (Figure [8B](#F8){ref-type="fig"}). We also examined the activation profile of PKD1 pS916 C-terminal phosphorylation. PKD1pS916 (red) was localized (pink/yellow) in both cytosol and nucleus of TH +ve primary mesencephalic neurons staining for green during H~2~O~2~-induced oxidative stress (Figure [8C](#F8){ref-type="fig"}).

Parkinsonian-specific toxicant causes PKD1 activation
-----------------------------------------------------

Activation of this signaling pathway was also tested using the parkinsonian-specific toxicant 6-OHDA. We treated N27 cells with 100 μM 6-OHDA and performed a time-course analysis for 1, 3, and 6 h. PKD1 activation started as early as 1 h and continued until 3 h before reaching control levels at around 6 h (Figure [9](#F9){ref-type="fig"}). This further confirmed the involvement of PKD1 signaling during parkinsonian-specific oxidative insult.

![**PKD1 is activated by 6-OHDA induced oxidative stress**. N27 dopaminergic neuronal cells were treated with or without 6-OHDA (100 μM) for 1, 3, and 6 h and probed for PKD1 activation loop phosphorylation pS744/pS748 and PKCδ cleavage.](1750-1326-6-43-9){#F9}

Discussion
==========

The present study reveals a novel protective compensatory signaling mechanism via PKCδ-PKD1 molecular interaction in dopaminergic neuronal cells. Through our collective results, we report for the first time four key findings in a dopaminergic neuronal model pertinent to oxidative stress-mediated neurodegenerative processes: (i) A proteolytically activated catalytic PKCδ fragment (PKCδ-CF) phosphorylates and activates protein kinase D1 (PKD1); (ii) PKD1 activation counteracts early stage oxidative damage and protects dopaminergic neuronal cells from cytotoxicity; (iii) PKCδ-dependent phosphorylation of ser 916 residue precedes ser 744/ser 748; (iv) PKCδ - PKD1 crosstalk tightly regulates cell survival and cell death to maintain cellular homeostasis in response to oxidative damage. The elucidation of this compensatory signal transduction mechanism in neurodegenerative diseases may enhance understanding of degenerative processes and lead to development of novel treatment modalities.

H~2~O~2~-induced cytotoxicity causes apoptosis in neuronal and non-neuronal cells \[[@B15],[@B43],[@B44],[@B50]\]. Generally, oxidative stress-induced apoptosis can be classified into early and late stages. DNA fragmentation occurs in the late stage of apoptosis and is preceded by ROS generation, mitochondrial dysfunction and caspase-3 activation and membrane phosphatidyl exposure \[[@B10],[@B47]\]. In neurodegenerative disorders, especially PD, the signaling mechanisms that contribute to increased vulnerability of dopaminergic neurons to oxidative damage are still under investigation. Most current research focuses on cell death mechanisms in dopaminergic neurons. Some of the signaling kinases responsible for cell death mechanisms in PD include JNK, MLK, MAPK, LRRK2, etc. \[[@B51]-[@B54]\]. Earlier, the involvement of a novel biochemical mechanism for cell death in dopaminergic neurons through caspase-mediated proteolytic activation of PKCδ was demonstrated \[[@B15]-[@B19]\]. The high levels of persistently active PKCδ catalytic fragment mediate apoptosis during oxidative stress in both cell culture and animal models of PD \[[@B15]-[@B19]\]. We also have shown in our earlier study that a positive feedback loop exists during the late stages of oxidative stress, where the persistently active PKCδ catalytic fragment translocates to the mitochondria to promote cytochrome C release and apoptosis \[[@B16],[@B17],[@B55]\].

We previously demonstrated proteolytic activation of PKCδ occurs during the early stages of oxidative stress, even before cell death can occur, and coincides with the initiation of mitochondrial ROS generation/caspase-3 activation in dopaminergic neurons \[[@B15],[@B17]\]. Thus, we speculated that proteolytically activated PKCδ might play a regulatory role during the early stages of apoptosis. Previous research suggests the presence of a variety of protective compensatory mechanisms that counteract the early oxidative insult \[[@B8]-[@B10]\]. Since we observed in our present study a significant lag time before induction of cell death during the early stages of oxidative stress (Figure [1B](#F1){ref-type="fig"}), we hypothesize that proteolytically activated PKCδ might sense the extent of oxidative damage and act as a homeostatic regulator in response to oxidative stress, modulating cell survival and cell death mechanisms through interactions with protective signaling molecules.

Protein kinase D1 (PKD1) is emerging as an important signaling molecule associated with oxidative stress in non-neuronal cell lines \[[@B31],[@B35],[@B36]\]. Studies have shown that oxidative stress increases PKD1 activation loop phosphorylation (pS744/pS748) via full length PKCs, including PKCδ, in non-neuronal models \[[@B37],[@B56]-[@B59]\]. However, the functions of PKD1 during oxidative stress-induced neurodegeneration have not been studied previously. In the present study, we report that cleaved active PKCδ phosphorylates the activation loop of PKD1 and activates the kinase during the early stages of H~2~O~2~-induced oxidative stress in dopaminergic neuronal cells. We also observed a similar activation pattern for PKD1 and PKCδ during oxidative stress caused by the parkinsonian-specific toxicant 6-OHDA (Figure [9](#F9){ref-type="fig"}). To our knowledge, this is the first report of a novel cell survival/cell death signal regulation by the cleaved catalytic fragment of PKCδ at two different stages of apoptosis based on the extent of oxidative damage.

PKD1 is mainly activated by a diacylglycerol-dependent PKCs mechanism \[[@B22],[@B60]\] or by PKD1 cleavage \[[@B61]-[@B63]\]. A recent study shows that PKD1 auto-inhibition is released through phosphorylation at the Y463 site in the regulatory domain, leading to the activation loop phosphorylation by PKCδ full length (PKCδ-FL) in Hela cells \[[@B24]\]. PKD1 is in a closed conformation during the resting stage, with the regulatory fragment having an autoinhibitory effect on the catalytic fragment \[[@B46],[@B64]\]. Multiple phosphorylation sites on PKD1 seem to be important for its activation loop phosphorylation, depending on the cell types and stimuli. In human cancer cell lines, PKD1 can be phosphorylated at multiple sites including Y463, S910 (corresponding to murine Y469, S916) \[[@B24],[@B65]\]. Phosphorylation of Ser 916 (murine) autophosphorylation site correlated with PKD1 activation loop phosphorylation \[[@B58],[@B66]\]. During oxidative stress in non-neuronal models, Tyr 469 is phosphorylated by upstream kinases, which results in release of the Pleckstrin homology (PH) domain autoinhibition prior to activation loop phosphorylation; this mechanism does not involve C-terminus Ser 916 phosphorylation \[[@B24],[@B37]\]. In our dopaminergic neuronal models, oxidative stress failed to induce PKD1 Tyr 469 phosphorylation (Figure [6A](#F6){ref-type="fig"}), whereas PKD1 Tyr 469 phosphorylation was induced by the positive control desmopressin (Figure [6B](#F6){ref-type="fig"}). Our results demonstrate that the mechanism of PKD1 activation in dopaminergic neurons is distinct from the mechanisms in other non-neuronal models. We demonstrate that S916 phosphorylation, but not Tyr 469 phosphorylation, is a preceding event that occurs and is required for PKD1ser744/Ser748 activation loop phosphorylation (Figure [6](#F6){ref-type="fig"}). Our data suggest that Ser 916 phosphorylation on the C-terminal of PKD1 may open the conformation for full activation of the kinase through activation loop phosphorylation during oxidative stress in dopaminergic neurons. A detailed comparative analysis of PKCδ proteolytic activation, PKD1 activation loop phosphorylation and the extent of cell death during oxidative stress revealed an interesting functional relationship between activation of kinases and regulation of cell death. Comparison of PKD1 activation and cytotoxicity shows that PKD1 activation is maximal during the early oxidative stress stage when no measurable cytotoxicity is noted (Figure [7A](#F7){ref-type="fig"}). Interestingly, when PKD1 activation begins to decline at the end of the early stage, cell death begins to occur. Also, the level of PKCδ proteolytic activation directly correlates with the extent of cell death at the later stage of oxidative stress. When the constitutively active PKD1 mutant (PKD1^S744E^/^S748E^) is overexpressed, dopaminergic cells are resistant to H~2~O~2~-induced neurotoxicity, even during the late stages of oxidative stress (Figure [7D](#F7){ref-type="fig"}), which is consistent with our hypothesis that PKD1 activation protects against oxidative damage. The downstream signaling mechanisms of PKD1 activation in dopaminergic neuronal cells are not known. PKD1 translocates to the nucleus and regulates phosphorylation of HDACs and various transcription factors in various non-neuronal cell lines including B cell, cardiomyocytes & oestoblasts \[[@B31],[@B23],[@B40],[@B67]\]. PKD1 translocation to the nucleus after activation in dopaminergic neurons is also noted in the present study (Figure [8](#F8){ref-type="fig"}), suggesting that nuclear translocation of PKD1 may activate key cell survival transcription factors and genes. Thus, we suggest that PKD1 functions as a cell survival switch and turns \'ON\' a protective compensatory mechanism in dopaminergic neurons. Studies are underway to characterize the downstream protective response of PKD1 signaling in nigral dopaminergic neurons.

Conclusions
===========

Our results demonstrate that the PKD1-mediated protective mechanism is a novel signal transduction pathway that regulates cell survival and cell death during various stages of oxidative stress in dopaminergic neuronal cells. As depicted in Figure [10](#F10){ref-type="fig"}, in the early stages of oxidative insult, PKCδ acts as an oxidative stress sensor/regulator and activates PKD1, which serves as a key compensatory protective mechanism against oxidative damage. However, prolonged oxidative insult creates a homeostatic imbalance, causing deactivation of PKD1 and persistent proteolytic activation of PKCδ that contribute to extensive neuronal damage. We previously showed a parallel proapoptotic mechanism involving translocation of PKCδ catalytic fragments to the mitochondria, resulting in a persistent increase in caspase-3 dependent PKCδ proteolytic cleavage via a positive feedback loop mechanism \[[@B16],[@B17],[@B55]\]. Our results suggest that positive modulation of the PKD1-mediated protective mechanism against oxidative damage in dopaminergic neurons may provide novel neuroprotective strategies for treatment of PD.

![**Schematic of PKCδ-PKD1 signal transduction mechanism during oxidative stress in dopaminergic neuronal cells**. 1) Oxidative stress causes mitochondrial impairment; 2) activation of caspase cascade; 3) caspase-3 mediates proteolytic cleavage of PKCδ; 4) proteolytically cleaved PKCδ-catalytic fragment (CF) is active; 5) PKCδ-CF activates PKD1 by activation loop phosphorylation during the early stage of oxidative stress; 6) Fully active PKD1 regulates cell survival function in N27 dopaminergic cells.](1750-1326-6-43-10){#F10}

Materials and methods
=====================

Cell Culture
------------

The immortalized rat mesencephalic dopaminergic neuronal cell line (N27) was a kind gift from Dr. Kedar N. Prasad (University of Colorado Health Sciences Center, Denver, CO). N27 cells were grown in RPMI 1640 medium containing 10% fetal bovine serum, 2 mm l-glutamine, 50 units of penicillin, and 50 μg/ml streptomycin. Cells were maintained in a humidified atmosphere of 5% CO2 at 37°C, as described previously \[[@B16]\]. N27 cells are used widely as a cell culture model for PD \[[@B20],[@B15],[@B21],[@B16],[@B68]\].

Primary mesencephalic neuronal culture
--------------------------------------

Primary mesencephalic neuronal cultures were prepared from the ventral mesencephalon of gestational 16- to 18-day-old mouse embryos, as described earlier \[[@B69]\]. Tissues were dissected from E16 to E18 mouse embryos maintained in ice cold Ca2+-free Hanks\' balanced salt solution and then dissociated in Hanks\' balanced salt solution containing trypsin-0.25% EDTA for 30 min at 37°C. The dissociated cells were then plated at equal density (0.5 × 106 cells) on 12 mm coverslips precoated with 0.1 mg/ml poly-D-lysine. Cultures were maintained in neurobasal medium fortified with B-27 supplements, 500 μM l-glutamine, 100 IU/ml penicillin, and 100 μg/ml streptomycin (Invitrogen). The cells were maintained in a humidified CO2 incubator (5% CO2 and 37°C). Half of the culture medium was replaced every 2 days. Approximately 6- to 7-day-old cultures were used for experiments. Primary mesencephalic dopaminergic neuronal cells were exposed to 10 μM for 1 h.

Treatment Paradigm
------------------

N27 cells were exposed to H~2~O~2~(100 μm) for 0-4 h at 37°C. Primary neurons were exposed to H~2~O~2~(10 μm) for 1 h. Cell lysates were used for Western blotting and immunoprecipitation studies. Untreated cells were grown in the complete medium and used as the experimental control.

Cytotoxicity Assays
-------------------

Cell death was determined using the Sytox green cytotoxicity assay, after exposing the N27 cells to H~2~O~2~(100 μm), as described previously. This cytotoxicity assay was optimized for a multiwell format, which is more efficient and sensitive than other cytotoxicity measurements \[[@B70],[@B71]\]. Briefly, N27 cells were grown in 24-well cell culture plates at 100,000 cells per well and treated with H~2~O~2~(100 μm) and 1 μm Sytox green fluorescent dye. The Sytox green assay allows dead cells to be viewed directly under a fluorescence microscope, as well as quantitatively measured with a fluorescence microplate reader (excitation 485 nm; emission 538 nm) (Biotek). Phase contrast and fluorescent images were taken after H~2~O~2~exposure with a NIKON TE2000 microscope, and pictures were captured with a SPOT digital camera.

ROS Generation Assay
--------------------

ROS generation was monitored by CM-DCFDA dye, as described previously \[[@B15],[@B72]\]. This is a non-fluorescent dye in its reduced form, but after oxidation in the cells, the acetate group is removed by cellular esterases, resulting in fluorescence. N27 cells were seeded in 48-well plates at a confluence of 40,000 cells/well for 24 h. First, cells were loaded with 10 μM CM-DCFDA dye (Invitrogen) at 37°C for 1 h in the dark. Cells were then treated with H~2~O~2~in Hanks\' balanced salt solution (HBSS) and the fluorescence of the cells was measured using the synergy 2 fluorescence plate reader (Biotek) at various time points (excitation 485 nm; emission 538 nm).

Immunocytochemistry
-------------------

The primary mesencephalic neurons or N27 cells after H~2~O~2~treatment were fixed with 4% paraformaldehyde and processed for immunocytochemical staining. First, nonspecific sites were blocked with 2% bovine serum albumin, 0.5% Triton and 0.05% Tween-20 in phosphate-buffered saline (PBS) for 20 min. The cells then were incubated with antibodies directed against TH, native PKD1 and PKD1-pS744/S748 in PBS containing 1% BSA at 4°C overnight, followed by incubation with Alexa 488 and Alexa 568 conjugated secondary antibodies in PBS containing 1% BSA. Secondary antibody treatments were followed by incubation with Hoechst 33342 dye for 5 min at room temperature to stain the nucleus. The coverslips containing stained cells were washed with PBS, mounted on slides, and viewed under a Nikon inverted fluorescence microscope (model TE-2000U; Nikon, Tokyo, Japan). Both fluorescence and confocal images were captured with a SPOT digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI).

Western Blot Analysis
---------------------

Cells were lysed in either modified RIPA buffer or M-PER buffer (Thermo Scientific) for Western blot, immunoprecipitation and kinase assays. Lysates containing equal amounts of protein were loaded in each lane and separated on 10-12% SDS-PAGE, as described previously (Kaul et al., 2003). PKD1 polyclonal (1:1000), PKCδ polyclonal (1: 1000), PKD1-pS744/S748 (1:1000), PKD1-pS916 (1:1000), PKD1-pY469 (1:1000), - and β-actin (1:10000) antibodies were used to blot the membranes. IR dye-800 conjugated anti-rabbit (1:5000) and Alexa Fluor 680 conjugated anti-mouse (1:10000) were used for antibody detection with the Odyssey IR Imaging system (LICOR), as previously described.

PKCδ Kinase Assay
-----------------

Immunoprecipitation and PKCδ kinase assay were performed as described earlier \[[@B15]\]. After cell lysis, cell were immunoprecipitated using a polyclonal PKCδ rabbit antibody and protein A Sepharose, and washed three times with PKCδ kinase buffer (40 mM Tris (pH 7.4), 20 mM MgCl~2~, 20 μM ATP, 2.5 mM CaCl2). The reaction was started by adding 20 μl of buffer containing 0.4 mg histone and 5 μCi of \[γ-^32^P\]ATP (4,500 Ci/mM). After incubation for 10 min at 30°C, SDS loading buffer (2X) was added to the samples to terminate the reaction. The reaction products were separated on SDS-PAGE (12%), and the H1-phosphorylated bands were detected using a phosphoimager (Fujifilm FLA-5100) and quantified with MultiGauge V3.0 software.

Protein Kinase D1 Kinase Assay
------------------------------

The cells were exposed to H~2~O~2~(100 μM) for 1 h and cell lysates were immunoprecipitated, as previously reported, with native PKD1 antibody (Santa Cruz). The kinase reaction was carried out at room temperature for 20 min after adding 10 μl of kinase substrate mix (0.1 mM ATP + 10 μci \[γ-^32^P\] ATP + 2 ug Syntide 2 peptide substrate in kinase buffer). Kinase buffer contains 20 mM Tris pH 7.5, 10 mM MgCl~2~, and 1 mM DTT. The samples were centrifuged to terminate the kinase reaction, and the supernatants containing the phosphorylated peptide were applied as spots to P81 phosphocellulose squares (Whatmann). The papers were washed four times with 0.75% phosphoric acid and once with acetone and dried, and activity was determined by liquid scintillation counting. The samples were also loaded on a SDS-PAGE and probed for native PKD1 to determine equal loading.

DNA Fragmentation Assay
-----------------------

DNA fragmentation was measured using the Cell Death Detection ELISA Plus assay kit (Roche), for the detection of early apoptotic death, as described previously \[[@B15],[@B72]\]. After 100 μm H~2~O~2~treatment, the cells were spun down at 200 × g for 5 min and washed once with PBS. Then cells were lysed with lysis buffer provided with the kit. After lysis, the samples were spun down at 10,000 rpm for 10 min to collect the supernatant that was used to measure DNA fragmentation. The supernatants were further dispensed into the microtiter plates coated with streptavidin containing HRP-conjugated antibody cocktail that can detect the nucleosomes. After 2 h incubation, the HRP substrate provided in the kit was added. Measurements were taken in a Synergy 2 multiwell plate reader at 405 nm, with 490 nm as a reference reading.

Transient and Stable Transfections
----------------------------------

cDNA encoding PKCδ catalytic fragment (PKCδ-CF), PKCδ regulatory fragment (PKCδ-RF) and PKCδ caspase-resistant mutant (PKCδ-CRM) (PKCδ^D327A)^from the pEGFPN1 vector were subcloned into the lentiviral expression vector plenti6/V5-d-TOPO in our lab (herein referred to as V5-PKCδ-CF, V5-PKCδ-RF, V5-PKCδ-CRM) \[[@B15],[@B73]\]. ViraPower Lentiviral Expression System (Invitrogen) was used to establish stable transfections of a caspase-resistant mutant of PKCδ^D327A^\[[@B73]\]. Full-length human PKD1 plasmid (PKD1-FL), PKD1 activation loop, active PKD1^S744E/S748E^(PKD1-CA) and PKD1^S916A^mutants were obtained from Addgene, Inc. \[[@B74],[@B49],[@B37]\]. Electroporation was carried out with an Amaxa Nucleofector transfector instrument, as per the manufacturer\'s protocol. The transfected cells were then transferred to T-75 flasks or 6-well plates as desired and allowed to grow for a 24 h period before the treatment.

RNAi
----

PKCδ-siRNA was prepared by an in vitro transcription method, as described previously \[[@B20]\]. PKCδ-siRNA effectively suppressed \> 80% of PKCδ protein expression levels within 24 h post-transfection. Predesigned PKD1-siRNA was purchased from IDT, Inc. PKD1-siRNA effectively suppressed \> 80% of PKD1 protein expression levels after 36 h post-transfection. N27 cells (50-70% confluence) were transfected with siRNA duplexes using an Amaxa Nucleofector kit (Amaxa), as described in our previous study \[[@B20]\].

Statistical Analysis
--------------------

Data analysis was performed using Prism 3.0 software (GraphPad Software, San Diego, CA). Bonferroni\'s multiple comparison testing was used to find the significant differences between treatment and control groups. Differences with p \< 0.05, p \< 0.01, and p \< 0.001 were considered significantly different from n ≥ 6 from two or more independent experiments, and are indicated in the figures.
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###### Additional file 1

**Rat PKD1 amino acid sequence obtained from Swiss-Prot database (ID: Q9WTQ1) was analyzed using Scansite Motif software to identify the upstream PKCs that phosphorylate the PKD1 activation loop serine residues**. The analysis done at high stringency shows that only PKCδ phosphorylates PKD1 at the activation loop residue Serine 744 site.

###### 
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###### Additional file 2

**N27 cells were transfected with 1 μM PKCα siRNA and non-specific siRNA and monitored for PKCα protein expression and PKD1pS744/S748 after H~2~O~2~treatment**. PKCα knockdown did not cause attenuation in PKD1 activation loop phosphorylation.
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